Sidley's 2026 San Diego Clinical Trial Series

Sidley’s Global Life Sciences team invites you to our three-part series on clinical trials in San Diego. This series is for biotech and life sciences companies exploring cutting-edge developments and seeking practical regulatory guidance on successfully navigating global clinical trial design, execution, and collaboration considerations.

Part I: U.S. Clinical Trial Design & Execution Risks | January 29, 2026
Explore the key regulatory, enforcement, operational, and contractual risks shaping today’s clinical trial landscape in the U.S., including FDA expectations and emerging compliance challenges.

Part II: Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health Insights |  March 12, 2026
Examine the structure of biotech collaboration and licensing agreements and the important implications for clinical trials, with a deeper dive into legal, regulatory and compliance issues for AI and digital health partnerships.

Part III: Global Trial Expansion — Key Considerations for EU/U.S. Sponsors | April 21, 2026
Explore how the EU and U.S. regulations impact global study planning and execution. Learn what U.S. sponsors should consider when transitioning between EU and U.S. for early-stage clinical trials to ensure compliance and accelerate development.

CLE credit for this series is pending.